Europe's generic drugmakers say they may cut output due to energy bills

28 September 2022 - Europe's drugmakers have warned they may stop making some cheap generic medicines because of surging electricity ...

Read more →

Most coronavirus tests cost about $100. Why did one cost $2,315?

16 June 2020 - U.S. health care prices are unregulated, opaque and unpredictable. When Congress required insurers to cover COVID-19 testing, ...

Read more →

Extended-release drugs could be costing U.S. health care system billions

1 March 2020 - If doctors prescribed short-acting medications that must be taken twice a day instead of once-a-day extended-release ...

Read more →

Innovation and access at the mercy of payment policy: the future of chimeric antigen receptor therapies

1 November 2019 - In 2017, the US FDA approved the first chimeric antigen receptor therapies (CAR-Ts), tisagenlecleucel and axicabtagene ...

Read more →

The U.S. health care system found a way to make peanuts cost $4,200

13 September 2019 - A new, billion-dollar pharmaceutical to treat peanut allergies is up for approval. It’s simply peanut flour. ...

Read more →

Why pharmaceutical companies are on a shopping binge

14 January 2019 - With the cost of R&D so high, it may make sense to spend money on a competitor. ...

Read more →

Novartis says SMA gene therapy is cost-effective at $4-5 million per patient

5 November 2018 - Novartis, which is shifting into rare diseases, said on Monday it believes its new gene therapy ...

Read more →

The ‘right to try’ could cost dying patients a fortune

21 June 2018 - Small biotech considers giving access under new U.S. law. ...

Read more →

Why Trump’s tariffs could raise the cost of a hip replacement

6 April 2018 - Pacemakers and artificial joints. Defibrillators. Dental fillings. Birth-control pills and vaccines. All are made in China, ...

Read more →

Breakthrough cancer treatments raise difficult questions

1 October 2017 - The approval of a first-of-its kind cancer therapy creates new challenges related to safety, access, and costs. ...

Read more →

Cheaper drug trials would lower prices: FDA chief

15 September 2017 - Decreasing the time and cost it takes to develop a drug would lower drug prices, FDA ...

Read more →

More new cancer drugs mean higher costs but also longer lives

1 June 2017 - Spending on cancer treatments has spiked past the $100 billion mark globally over the past five ...

Read more →

AusBiotech suggests FSANZ amend cost recovery plan

21 February 2017 - AusBiotech has responded to Food Standards Australia New Zealand (FSANZ) call for comment on the draft ...

Read more →

Costs keep women from taking drugs to prevent cancer’s return

1 November 2016 - Poverty and higher out-of-pocket drug costs may be the main reason that some women don’t stick ...

Read more →

How health care hurts your paycheck

2 November 2016 - If there is a coherent theme to this year’s election, it is the growing economic frustration ...

Read more →